Advertisement rdharma@digitalinsightresearch.in, Author at Pharmaceutical Business review - Page 24 of 50

Advertisement

Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Maze Therapeutics launches with $191m financing

Maze Therapeutics has secured an initial investment commitment of $191m, led by Third Rock Ventures and ARCH Venture Partners. GV, Foresite Capital, Casdin Capital, Alexandria Venture Investments and